Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Juliana E. Gilbert"'
Autor:
Glenda G. Callender, Charles R. Scoggins, Robert C.G. Martin, Alison L. Burton, Arnold J. Stromberg, Merrick I. Ross, Kelly M. McMasters, Russell W. Farmer, Juliana E. Gilbert, Lee Hagendoorn
Publikováno v:
The American Surgeon. 77:1009-1013
Controversy exists regarding the prognostic implications of regression in patients with cutaneous melanoma. Some consider regression to be an indication for sentinel lymph node (SLN) biopsy because regression may result in underestimation of the true
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8535d07ee6020c2981407482b136791b
https://doi.org/10.1177/000313481107700819
https://doi.org/10.1177/000313481107700819
Publikováno v:
JAMA dermatology. 150(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3fcdfe6a83c21cd812afc32cd5a86a8
https://pubmed.ncbi.nlm.nih.gov/24599173
https://pubmed.ncbi.nlm.nih.gov/24599173
Autor:
Juliana E. Gilbert, Kelly M. McMasters, Lee Hagendoorn, Michael E. Egger, Alison L. Burton, Charles R. Scoggins, Glenda G. Callender, Robert C.G. Martin, Arnold J. Stromberg
Publikováno v:
American journal of surgery. 204(6)
Background In patients with cutaneous melanoma, mitotic rate (MR) historically has been reported as the number of mitoses per high-power field (hpf) or per 10 hpf. The most recent revision of the American Joint Committee on Cancer melanoma staging sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1f07ff8720b853f7a186246942e03c
https://pubmed.ncbi.nlm.nih.gov/23668722
https://pubmed.ncbi.nlm.nih.gov/23668722
Autor:
Ryaz B. Chagpar, Charles R. St. Hill, Charles R. Scoggins, Kelly M. McMasters, Robert C.G. Martin, Glenda G. Callender, Russell E. Brown, Juliana E. Gilbert
Publikováno v:
Annals of surgical oncology. 19(1)
While several prognostic models have been developed to predict survival of patients who undergo hepatectomy for metastatic colorectal cancer (mCRC), few data exist to predict survival after recurrence. We sought to develop a model that predicts survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::047b6c2c8f1f2cf243b8c1c0d9d89d8d
https://pubmed.ncbi.nlm.nih.gov/21751045
https://pubmed.ncbi.nlm.nih.gov/21751045
Autor:
Adam S. Brinkman, Hong Jin Kim, Robert C.G. Martin, Emily R. Winslow, Juliana E. Gilbert, Charles R. Scoggins, Kelly M. McMasters, Christopher C. Rupp, Syed A. Ahmad, Sharon M. Weber, Ryaz B. Chagpar, Carrie K. Chu, Andrew J. Ebelhar, Clifford S. Cho, Charles A. Staley, David A. Kooby
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 15(4)
Although patients with pancreatic ductal adenocarcinoma (PDAC) frequently require medications to treat pre-existing conditions, the impact of these treatments on outcomes post-resection is unknown. The purpose of this study was to determine the impac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c736cfeac00501bf1c84a0f40836a7d0
https://pubmed.ncbi.nlm.nih.gov/21327533
https://pubmed.ncbi.nlm.nih.gov/21327533